A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
Clinical trial NCT06181032 · RECRUITING
Trial details
- NCT number
- NCT06181032
- Sponsor
- First Affiliated Hospital of Fujian Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-23
- Primary completion
- 2029-02-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.